Cancer diagnostics company raises $2.5m seed funding:
This article was originally published in Clinica
Executive Summary
VC firm Kodiak Venture Partners has invested $2.5m in Cambridge Devices, a Cambridge, Massachusetts start-up focused on technologies for improving cancer diagnostics. The company, established in 2004, is developing two medical devices; the tissue identification probe is designed to enable more accurate diagnosis of breast cancer, while the fluorescence polarisation imaging system is to help doctors excise skin cancers more effectively and reduce recurrence of cancerous cells.
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.